文献速递浆细胞疾病

细胞因子受体IL27RA是NF-κB应答基因并参与多发性骨髓瘤CD38上调

Cytokine receptor IL27RA is an NF-κB-responsive gene involved in CD38 upregulation in multiple myeloma.
PubMed 文献 · Blood Adv · 2023-01-01

研究确定多发性骨髓瘤(MM)细胞系中RELA依赖的转录程序,发现IL-27Rα和JAM2受RELA调控,且在MM原代细胞上表达高于健康长寿浆细胞;IL-27激活STAT1和STAT3,与IL-21协同增强浆细胞分化并上调CD38表面表达,部分MM细胞系和原代细胞经IL-27培养后CD38上调,可能增强CD38靶向单抗疗效。

要点

  • MM细胞系中IL-27Rα和JAM2的表达受RELA调控。
  • IL-27Rα和JAM2在MM原代细胞表达高于健康长寿浆细胞。
  • IL-27与IL-21协同增强浆细胞分化并上调CD38表达。

核心结论

  • IL27RA是NF-κB应答基因,参与MM细胞CD38上调,靶向IL-27Rα/JAM2或增强CD38靶向治疗具潜在价值。

研究设计与样本

  • 研究采用MM细胞系及原代MM细胞,结合IL-21依赖的体外浆细胞分化实验进行分析。

主要发现

  • 部分MM细胞系生长存活依赖经典NF-κB转录因子RELA。
  • IL-27Rα和JAM2在mRNA和蛋白水平受RELA调控。
  • IL-27Rα和JAM2在MM原代细胞表达高于骨髓健康长寿浆细胞。
  • IL-27在MM细胞系及体外分化浆细胞中激活STAT1,较弱激活STAT3。
  • IL-21与IL-27共同作用增强浆细胞分化并增加CD38表面表达。

临床怎么用

  • 原文指出提高肿瘤细胞CD38表达可能增强CD38靶向单抗疗效。
  • 原文指出MM细胞IL-27Rα和JAM2高表达或可用于开发调控肿瘤微环境相互作用的靶向策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple myeloma (MM) shows constitutive activation of canonical and noncanonical nuclear factor κB (NF-κB) signaling via genetic mutations or tumor microenvironment (TME) stimulations. A subset of MM cell lines showed dependency for cell growth and survival on the canonical NF-κB transcription factor RELA alone, suggesting a critical role for a RELA-mediated biological program in MM pathogenesis. Here, we determined the RELA-dependent transcriptional program in MM cell lines and found the expression of the cell surface molecules interleukin-27 receptor-α (IL-27Rα) and the adhesion molecule JAM2 to be responsive to RELA at the messenger RNA and protein levels. IL-27Rα and JAM2 were expressed on primary MM cells at higher levels than on healthy long-lived plasma cells (PCs) in the bone marrow. IL-27 activated STAT1, and to a lesser extent STAT3, in MM cell lines and in PCs generated from memory B cells in an IL-21-dependent in vitro PC differentiation assay. Concomitant activity of IL-21 and IL-27 enhanced differentiation into PCs and increased the cell-surface expression of the known STAT target gene CD38. In accordance, a subset of MM cell lines and primary MM cells cultured with IL-27 upregulated CD38 cell-surface expression, a finding with potential implications for enhancing the efficacy of CD38-directed monoclonal antibody therapies by increasing CD38 expression on tumor cells. The elevated expression of IL-27Rα and JAM2 on MM cells compared with that on healthy PCs may be exploited for the development of targeted therapeutic strategies that modulate the interaction of MM cells with the TME.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Brownlie RJ, Kennedy R, Wilson EB, et al. Cytokine receptor IL27RA is an NF-κB-responsive gene involved in CD38 upregulation in multiple myeloma. Blood Adv. 2023. PMID: 36867577. doi:10.1182/bloodadvances.2022009044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。